ECT2 and glioma: In conclusion, GINS2 regulated the TMZ sensitivity of glioma through the EGR1/ECT2 axis as well as the DDR pathway, and the GINS2–EGR1–ECT2 pathway has clinical implications for predicting the prognosis of glioma patients.